123 related articles for article (PubMed ID: 8967884)
1. The effects and pharmacokinetics of rhG-CSF in patients with chronic renal failure.
Akizawa T; Shishido K; Koshikawa S
Artif Organs; 1995 Dec; 19(12):1251-7. PubMed ID: 8967884
[TBL] [Abstract][Full Text] [Related]
2. [The effects and pharmacokinetics of rhG-CSF on the treatment of neutropenia in patients with renal failure].
Shishido K; Niikura K; Akizawa T; Koshikawa S
Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):973-81. PubMed ID: 1722829
[TBL] [Abstract][Full Text] [Related]
3. A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia.
Gillan ER; Christensen RD; Suen Y; Ellis R; van de Ven C; Cairo MS
Blood; 1994 Sep; 84(5):1427-33. PubMed ID: 7520770
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and Pharmacodynamics of Two Formulations of Pegylated Recombinant Human Granulocyte Colony-Stimulating Factor in Healthy Chinese Subjects: An Open-Label, Randomized, Parallel-Design Bioavailability Study.
Hu C; Ji B; Hu X; Yang C; Sun W; Zhao X; Li L; Li X; Zhang L
Clin Pharmacol Drug Dev; 2021 Mar; 10(3):291-298. PubMed ID: 32567217
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic/pharmacodynamic analysis of neutrophil proliferation induced by recombinant granulocyte colony-stimulating factor (rhG-CSF): comparison between intravenous and subcutaneous administration.
Sugiura M; Yamamoto K; Sawada Y; Iga T
Biol Pharm Bull; 1997 Jun; 20(6):684-9. PubMed ID: 9212991
[TBL] [Abstract][Full Text] [Related]
6. [Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) in patients receiving chemotherapy--phase I study].
Fukutani H; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nagamine D; Shinagawa K; Tabata M; Hirano A; Mizunuma N
Gan To Kagaku Ryoho; 1989 May; 16(5):2005-12. PubMed ID: 2471461
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of endogenous and exogenous granulocyte colony-stimulating factor after autologous blood stem cell transplantation.
Shimazaki C; Uchiyama H; Fujita N; Araki S; Sudo Y; Yamagata N; Ashihara E; Goto H; Inaba T; Haruyama H
Exp Hematol; 1995 Dec; 23(14):1497-502. PubMed ID: 8542937
[TBL] [Abstract][Full Text] [Related]
8. Close association between clearance of recombinant human granulocyte colony-stimulating factor (G-CSF) and G-CSF receptor on neutrophils in cancer patients.
Terashi K; Oka M; Ohdo S; Furukubo T; Ikeda C; Fukuda M; Soda H; Higuchi S; Kohno S
Antimicrob Agents Chemother; 1999 Jan; 43(1):21-4. PubMed ID: 9869559
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor conjugated to polyethylene glycol in rats.
Tanaka H; Satake-Ishikawa R; Ishikawa M; Matsuki S; Asano K
Cancer Res; 1991 Jul; 51(14):3710-4. PubMed ID: 1712246
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and adverse events following 5-day repeated administration of lenograstim, a recombinant human granulocyte colony-stimulating factor, in healthy subjects.
Akizuki S; Mizorogi F; Inoue T; Sudo K; Ohnishi A
Bone Marrow Transplant; 2000 Nov; 26(9):939-46. PubMed ID: 11100272
[TBL] [Abstract][Full Text] [Related]
11. [Phase I clinical trail of intravenous pegylated recombinant human granulocyte colony-stimulating factor].
Shi YK; Liu P; Yang S; Han XH; He XH; Ai B; Qin Y; Li B; Huang DZ; Zhang CG; Sun Y
Ai Zheng; 2006 Apr; 25(4):495-500. PubMed ID: 16613688
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic studies of intravenous glycosylated recombinant human granulocyte colony-stimulating factor in various hematological disorders: inverse correlation between the half-life and bone marrow myeloid cell pool.
Watari K; Ozawa K; Takahashi S; Tojo A; Tani K; Kamachi S; Asano S
Int J Hematol; 1997 Jul; 66(1):57-67. PubMed ID: 9220661
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor in the rat. Single and multiple dosing studies.
Tanaka H; Kaneko T
Drug Metab Dispos; 1991; 19(1):200-4. PubMed ID: 1708329
[TBL] [Abstract][Full Text] [Related]
14. [Changes in neutrophil counts and functions after the administration of recombinant human granulocyte colony-stimulating factor in a patient with chronic idiopathic neutropenia].
Sai M; Kawanishi Y; Kuriyama K; Kuratsuji T; Toyama K
Rinsho Ketsueki; 1990 Apr; 31(4):484-6. PubMed ID: 1696326
[TBL] [Abstract][Full Text] [Related]
15. Seven-day administration of recombinant human granulocyte colony-stimulating factor to newborn rats: modulation of neonatal neutrophilia, myelopoiesis, and group B Streptococcus sepsis.
Cairo MS; Plunkett JM; Mauss D; Van de ven C
Blood; 1990 Nov; 76(9):1788-94. PubMed ID: 1699622
[TBL] [Abstract][Full Text] [Related]
16. In vivo effects of recombinant human granulocyte colony-stimulating factor on normal neutrophil function and membrane effector molecule expression.
Itoh Y; Kuratsuji T; Tsunawaki S; Aizawa S; Toyama K
Int J Hematol; 1991 Dec; 54(6):463-9. PubMed ID: 1724390
[TBL] [Abstract][Full Text] [Related]
17. Timing of recombinant human granulocyte colony-stimulating factor administration on neutropenia induced by cyclophosphamide in normal mice.
Misaki M; Ueyama Y; Tsukamoto G; Matsumura T
Br J Cancer; 1998 Mar; 77(6):884-9. PubMed ID: 9528829
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in the pharmacokinetics of recombinant human granulocyte colony-stimulating factor in the rat.
Tanaka H; Kaneko T
Drug Metab Dispos; 1991; 19(6):1034-9. PubMed ID: 1724959
[TBL] [Abstract][Full Text] [Related]
19. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.
Kocherlakota P; La Gamma EF
Pediatrics; 1997 Jul; 100(1):E6. PubMed ID: 9200380
[TBL] [Abstract][Full Text] [Related]
20. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on respiratory burst activity of neutrophils in patients with myelodysplastic syndromes.
Ohsaka A; Kitagawa S; Yuo A; Motoyoshi K; Furusawa S; Miura Y; Takaku F; Saito M
Clin Exp Immunol; 1993 Feb; 91(2):308-13. PubMed ID: 7679062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
